68Ga-前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)与多参数(mp)MRI 使用全 mount 病理检测中级别前列腺内前列腺癌的诊断准确性:将 68Ga-PSMA PET 加入 mpMRI 的影响
研究纳入 56 例根治性前列腺切除术后国际泌尿病理学会(ISUP)2-3 级前列腺癌患者,术前均行 mpMRI 和 PSMA-PET CT。在 12 段模型中,PSMA-PET 检测 ISUP ≥2 级癌的曲线下面积、灵敏度、特异度、阴性预测值和阳性预测值分别为 0.91、88%、93%、95% 和 85%,均优于 mpMRI(PI-RADS 3-5)的 0.79、68%、91%、87% 和 75%。两者联合(PSMA-PET 联合 mpMRI PI-RADS 4-5)的灵敏度、特异度、阴性预测值和阳性预测值分别为 92%、90%、96% 和 81%。
要点
- PSMA-PET 检测 ISUP ≥2 级前列腺癌的灵敏度为 88%,高于 mpMRI 的 68%。
- PSMA-PET 联合 mpMRI PI-RADS 4-5 的灵敏度为 92%,特异度为 90%。
- PSMA-PET 和 mpMRI 对 ISUP 1 级癌的灵敏度均低,分别为 18% 和 10%。
核心结论
- PSMA-PET 检测含有中级别前列腺内前列腺癌(ISUP ≥2 级)的段是准确的,与 mpMRI 相比具有互补性。
- PSMA-PET 和 mpMRI 对 ISUP 1 级疾病的检出率均低。
研究设计与样本
- 本研究纳入 56 例根治性前列腺切除术后国际泌尿病理学会(ISUP)2-3 级前列腺癌患者,术前均行 mpMRI 和 PSMA-PET CT。
- 在 12 段模型中分析 PSMA-PET、单独 mpMRI 及两者联合识别 ISUP 1-3 级的准确性,并确定联合预测模型(PSMA-PET 和 mpMRI)的准确性。
- 进行受试者工作特征曲线分析以确定 PSMA-PET 区分 ISUP 1 级与 ≥2 级的最佳标准化摄取值(SUVmax)。
主要发现
- 基于患者分析,PSMA-PET 和 mpMRI 识别 ISUP 2-3 级前列腺癌的灵敏度分别为 100% 和 97%。
- 在 12 段分析中评估 ISUP ≥2 级前列腺癌时,PSMA-PET 的曲线下面积、灵敏度、特异度、阴性预测值和阳性预测值分别为 0.91、88%、93%、95% 和 85%,优于 mpMRI(PI-RADS 3-5)的 0.79、68%、91%、87% 和 75%。
- 两者联合(PSMA-PET 和 mpMRI PI-RADS 4-5)时,灵敏度、特异度、阴性预测值和阳性预测值分别为 92%、90%、96% 和 81%。
- 评估 ISUP 1 级前列腺癌时,两种技术的灵敏度均显著降低,PSMA-PET 为 18%,mpMRI 为 10%。
- SUVmax 值为 3.95 时,灵敏度为 94%,特异度为 100%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the ability of prostate-specific membrane antigen (PSMA)-positron-emission tomography (PET)/computed tomography (CT) to detect intermediate-grade intra-prostatic prostate cancer (PCa), and to determine if PSMA-PET improves the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI). PATIENTS AND METHODS: A total of 56 consecutive patients with International Society of Urological Pathology (ISUP) grade 2-3 PCa after radical prostatectomy, who underwent both mpMRI and PSMA-PET CT (hereafter PSMA-PET) preoperatively, were enrolled in this study. The accuracy of PSMA-PET, mpMRI alone, and the two procedures in combination was analysed for identifying ISUP grades 1-3 within a 12-segment model. The accuracy of a combined predictive model (PSMA-PET and mpMRI) was determined. Receiver-operating characteristic curve analysis to determine the optimal standardized uptake value (SUVmax ) for PSMA-PET in discriminating between ISUP grades 1 and ≥2 was performed. RESULTS: On a per-patient basis, the sensitivities for PSMA-PET and mpMRI in identifying ISUP grades 2-3 PCa were 100% and 97%, respectively. Assessing ISUP grade ≥2 PCa using a 12-segment analysis, PSMA-PET demonstrated greater diagnostic accuracy (area under the curve), sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV), with values of 0.91, 88%, 93%, 95% and 85%, respectively, than did mpMRI (Prostate Imaging Reporting and Data System [PI-RADS] 3-5), at 0.79, 68%, 91%, 87%, and 75%, respectively. When used in combination (PSMA-PET and mpMRI PIRADS 4-5), sensitivity, specificity, NPV and PPV were 92%, 90%, 96% and 81%, respectively. The sensitivity for both techniques reduced markedly when assessing ISUP grade 1 PCa (18% for PSMA-PET, 10% for mpMRI). An SUVmax value of 3.95 resulted in 94% sensitivity and 100% specificity. CONCLUSION: PSMA-PET is accurate in detecting segments containing intermediate-grade intra-prostatic PCa (ISUP grade ≥ 2), compared with and complementary to mpMRI. By contrast the detection rate for ISUP grade 1 disease for both PSMA-PET and mpMRI was low.
引用
- Scheltema MJ, Chang JI, Stricker PD, et al. Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI. BJU Int. 2019. PMID: 31287613. doi:10.1111/bju.14794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。